| Identification | Back Directory | [Name]
SD-208 | [CAS]
627536-09-8 | [Synonyms]
SD-208
CS-2295
SCI 208
SD-208 10MG
SD-208 (SD 208
ALK5 Inhibitor V
SD-208 USP/EP/BP
TGF-β RI Kinase Inhibitor V
SD-208;SD 208; SD208; SCI 208
SD 208;SD208;TGF-Β RI KINASE INHIBITOR V
2-(5-chloro-2-fluorophenyl)-N-4-pyridinyl-
2-(5-Chloro-2-fluorophenyl)-N-4-pyridinyl-4-pteridinamine
2-(5-Chloro-2-fluorophenyl)-4-[(4-pyridyl)amino]pteridine
4-PteridinaMine, 2-(5-chloro-2-fluorophenyl)-N-4-pyridinyl-
2-(5-chloro-2-fluorophenyl)-N-(pyridin-4-yl)pteridin-4-amine
2-[(5-CHLORO-2-FLUOROPHENYL)PTERIDIN-4-YL]PYRIDIN-4-YL-AMINE | [Molecular Formula]
C17H10ClFN6 | [MDL Number]
MFCD09038685 | [MOL File]
627536-09-8.mol | [Molecular Weight]
352.753 |
| Hazard Information | Back Directory | [Uses]
SD-208 was used to inhibit the activity of ALK5 kinase in bovine retinal vascular cells.2 | [Biological Activity]
Potent, orally active ATP-competitive transforming growth factor- β receptor 1 (TGF- β RI) inhibitor (IC 50 = 49nM). Displays > 100-fold and > 17-fold selectivity over TGF- β RII and other common kinases respectively. Exhibits anti-inflammatory and antitumor activity. | [Biochem/physiol Actions]
SD-208 is an inhibitor of TGF β receptor 1 kinase that is reportedly effective against human malignant gliomas. It increases the lytic activity and tumor infiltration by polyclonal natural killer cells, CD8 T cells and macrophages.1 | [storage]
Store at RT |
|
|